img

Global Toxoid Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Toxoid Market Insights, Forecast to 2034

Toxoid is a group of toxins that have been denatured or chemically modified to lose their original toxicity but retain their immunogenicity.
Global Toxoid market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Toxoid industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Toxoid key manufacturers include Biocompare, GSK, Zoetis, Sanofi and Merck, etc. Biocompare, GSK, Zoetis are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Toxoid were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Toxoid market and estimated to attract more attentions from industry insiders and investors.
Toxoid can be divided into Tetanic Toxoid, Diphtheria Toxoid and Others,, etc. Tetanic Toxoid is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Toxoid is widely used in various fields, such as Hospitals, Clinics and Others,, etc. Hospitals provides greatest supports to the Toxoid industry development. In 2022, global % sales of Toxoid went into Hospitals filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Toxoid market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Toxoid market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Biocompare
GSK
Zoetis
Sanofi
Merck
Segment by Type
Tetanic Toxoid
Diphtheria Toxoid
Others

Segment by Application


Hospitals
Clinics
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Toxoid plant distribution, commercial date of Toxoid, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Toxoid introduction, etc. Toxoid Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Toxoid
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Toxoid Product Introduction
1.2 Market by Type
1.2.1 Global Toxoid Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Tetanic Toxoid
1.2.3 Diphtheria Toxoid
1.2.4 Others
1.3 Market by Application
1.3.1 Global Toxoid Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Toxoid Sales Estimates and Forecasts 2018-2029
2.2 Global Toxoid Revenue by Region
2.2.1 Global Toxoid Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Toxoid Revenue by Region (2018-2024)
2.2.3 Global Toxoid Revenue by Region (2024-2029)
2.2.4 Global Toxoid Revenue Market Share by Region (2018-2029)
2.3 Global Toxoid Sales Estimates and Forecasts 2018-2029
2.4 Global Toxoid Sales by Region
2.4.1 Global Toxoid Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Toxoid Sales by Region (2018-2024)
2.4.3 Global Toxoid Sales by Region (2024-2029)
2.4.4 Global Toxoid Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Toxoid Sales by Manufacturers
3.1.1 Global Toxoid Sales by Manufacturers (2018-2024)
3.1.2 Global Toxoid Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Toxoid in 2022
3.2 Global Toxoid Revenue by Manufacturers
3.2.1 Global Toxoid Revenue by Manufacturers (2018-2024)
3.2.2 Global Toxoid Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Toxoid Revenue in 2022
3.3 Global Key Players of Toxoid, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Toxoid Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Toxoid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Toxoid, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Toxoid, Product Offered and Application
3.8 Global Key Manufacturers of Toxoid, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Toxoid Sales by Type
4.1.1 Global Toxoid Historical Sales by Type (2018-2024)
4.1.2 Global Toxoid Forecasted Sales by Type (2024-2029)
4.1.3 Global Toxoid Sales Market Share by Type (2018-2029)
4.2 Global Toxoid Revenue by Type
4.2.1 Global Toxoid Historical Revenue by Type (2018-2024)
4.2.2 Global Toxoid Forecasted Revenue by Type (2024-2029)
4.2.3 Global Toxoid Revenue Market Share by Type (2018-2029)
4.3 Global Toxoid Price by Type
4.3.1 Global Toxoid Price by Type (2018-2024)
4.3.2 Global Toxoid Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Toxoid Sales by Application
5.1.1 Global Toxoid Historical Sales by Application (2018-2024)
5.1.2 Global Toxoid Forecasted Sales by Application (2024-2029)
5.1.3 Global Toxoid Sales Market Share by Application (2018-2029)
5.2 Global Toxoid Revenue by Application
5.2.1 Global Toxoid Historical Revenue by Application (2018-2024)
5.2.2 Global Toxoid Forecasted Revenue by Application (2024-2029)
5.2.3 Global Toxoid Revenue Market Share by Application (2018-2029)
5.3 Global Toxoid Price by Application
5.3.1 Global Toxoid Price by Application (2018-2024)
5.3.2 Global Toxoid Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Toxoid Market Size by Type
6.1.1 US & Canada Toxoid Sales by Type (2018-2029)
6.1.2 US & Canada Toxoid Revenue by Type (2018-2029)
6.2 US & Canada Toxoid Market Size by Application
6.2.1 US & Canada Toxoid Sales by Application (2018-2029)
6.2.2 US & Canada Toxoid Revenue by Application (2018-2029)
6.3 US & Canada Toxoid Market Size by Country
6.3.1 US & Canada Toxoid Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Toxoid Sales by Country (2018-2029)
6.3.3 US & Canada Toxoid Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Toxoid Market Size by Type
7.1.1 Europe Toxoid Sales by Type (2018-2029)
7.1.2 Europe Toxoid Revenue by Type (2018-2029)
7.2 Europe Toxoid Market Size by Application
7.2.1 Europe Toxoid Sales by Application (2018-2029)
7.2.2 Europe Toxoid Revenue by Application (2018-2029)
7.3 Europe Toxoid Market Size by Country
7.3.1 Europe Toxoid Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Toxoid Sales by Country (2018-2029)
7.3.3 Europe Toxoid Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Toxoid Market Size
8.1.1 China Toxoid Sales (2018-2029)
8.1.2 China Toxoid Revenue (2018-2029)
8.2 China Toxoid Market Size by Application
8.2.1 China Toxoid Sales by Application (2018-2029)
8.2.2 China Toxoid Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Toxoid Market Size by Type
9.1.1 Asia Toxoid Sales by Type (2018-2029)
9.1.2 Asia Toxoid Revenue by Type (2018-2029)
9.2 Asia Toxoid Market Size by Application
9.2.1 Asia Toxoid Sales by Application (2018-2029)
9.2.2 Asia Toxoid Revenue by Application (2018-2029)
9.3 Asia Toxoid Sales by Region
9.3.1 Asia Toxoid Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Toxoid Revenue by Region (2018-2029)
9.3.3 Asia Toxoid Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Toxoid Market Size by Type
10.1.1 Middle East, Africa and Latin America Toxoid Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Toxoid Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Toxoid Market Size by Application
10.2.1 Middle East, Africa and Latin America Toxoid Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Toxoid Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Toxoid Sales by Country
10.3.1 Middle East, Africa and Latin America Toxoid Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Toxoid Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Toxoid Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Biocompare
11.1.1 Biocompare Company Information
11.1.2 Biocompare Overview
11.1.3 Biocompare Toxoid Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Biocompare Toxoid Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Biocompare Recent Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Overview
11.2.3 GSK Toxoid Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 GSK Toxoid Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Zoetis
11.3.1 Zoetis Company Information
11.3.2 Zoetis Overview
11.3.3 Zoetis Toxoid Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Zoetis Toxoid Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Zoetis Recent Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Overview
11.4.3 Sanofi Toxoid Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Sanofi Toxoid Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi Recent Developments
11.5 Merck
11.5.1 Merck Company Information
11.5.2 Merck Overview
11.5.3 Merck Toxoid Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Merck Toxoid Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merck Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Toxoid Industry Chain Analysis
12.2 Toxoid Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Toxoid Production Mode & Process
12.4 Toxoid Sales and Marketing
12.4.1 Toxoid Sales Channels
12.4.2 Toxoid Distributors
12.5 Toxoid Customers
13 Market Dynamics
13.1 Toxoid Industry Trends
13.2 Toxoid Market Drivers
13.3 Toxoid Market Challenges
13.4 Toxoid Market Restraints
14 Key Findings in The Global Toxoid Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Toxoid Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Tetanic Toxoid
Table 3. Major Manufacturers of Diphtheria Toxoid
Table 4. Major Manufacturers of Others
Table 5. Global Toxoid Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Toxoid Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Toxoid Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Toxoid Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Toxoid Revenue Market Share by Region (2018-2024)
Table 10. Global Toxoid Revenue Market Share by Region (2024-2029)
Table 11. Global Toxoid Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Toxoid Sales by Region (2018-2024) & (K Units)
Table 13. Global Toxoid Sales by Region (2024-2029) & (K Units)
Table 14. Global Toxoid Sales Market Share by Region (2018-2024)
Table 15. Global Toxoid Sales Market Share by Region (2024-2029)
Table 16. Global Toxoid Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Toxoid Sales Share by Manufacturers (2018-2024)
Table 18. Global Toxoid Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Toxoid Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Toxoid, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Toxoid Price by Manufacturers 2018-2024 (USD/Unit)
Table 22. Global Toxoid Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Toxoid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Toxoid as of 2022)
Table 24. Global Key Manufacturers of Toxoid, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Toxoid, Product Offered and Application
Table 26. Global Key Manufacturers of Toxoid, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Toxoid Sales by Type (2018-2024) & (K Units)
Table 29. Global Toxoid Sales by Type (2024-2029) & (K Units)
Table 30. Global Toxoid Sales Share by Type (2018-2024)
Table 31. Global Toxoid Sales Share by Type (2024-2029)
Table 32. Global Toxoid Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Toxoid Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Toxoid Revenue Share by Type (2018-2024)
Table 35. Global Toxoid Revenue Share by Type (2024-2029)
Table 36. Toxoid Price by Type (2018-2024) & (USD/Unit)
Table 37. Global Toxoid Price Forecast by Type (2024-2029) & (USD/Unit)
Table 38. Global Toxoid Sales by Application (2018-2024) & (K Units)
Table 39. Global Toxoid Sales by Application (2024-2029) & (K Units)
Table 40. Global Toxoid Sales Share by Application (2018-2024)
Table 41. Global Toxoid Sales Share by Application (2024-2029)
Table 42. Global Toxoid Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Toxoid Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Toxoid Revenue Share by Application (2018-2024)
Table 45. Global Toxoid Revenue Share by Application (2024-2029)
Table 46. Toxoid Price by Application (2018-2024) & (USD/Unit)
Table 47. Global Toxoid Price Forecast by Application (2024-2029) & (USD/Unit)
Table 48. US & Canada Toxoid Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Toxoid Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Toxoid Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Toxoid Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Toxoid Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Toxoid Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Toxoid Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Toxoid Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Toxoid Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Toxoid Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Toxoid Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Toxoid Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Toxoid Sales by Country (2024-2029) & (K Units)
Table 61. Europe Toxoid Sales by Type (2018-2024) & (K Units)
Table 62. Europe Toxoid Sales by Type (2024-2029) & (K Units)
Table 63. Europe Toxoid Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Toxoid Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Toxoid Sales by Application (2018-2024) & (K Units)
Table 66. Europe Toxoid Sales by Application (2024-2029) & (K Units)
Table 67. Europe Toxoid Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Toxoid Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Toxoid Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Toxoid Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Toxoid Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Toxoid Sales by Country (2018-2024) & (K Units)
Table 73. Europe Toxoid Sales by Country (2024-2029) & (K Units)
Table 74. China Toxoid Sales by Type (2018-2024) & (K Units)
Table 75. China Toxoid Sales by Type (2024-2029) & (K Units)
Table 76. China Toxoid Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Toxoid Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Toxoid Sales by Application (2018-2024) & (K Units)
Table 79. China Toxoid Sales by Application (2024-2029) & (K Units)
Table 80. China Toxoid Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Toxoid Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Toxoid Sales by Type (2018-2024) & (K Units)
Table 83. Asia Toxoid Sales by Type (2024-2029) & (K Units)
Table 84. Asia Toxoid Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Toxoid Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Toxoid Sales by Application (2018-2024) & (K Units)
Table 87. Asia Toxoid Sales by Application (2024-2029) & (K Units)
Table 88. Asia Toxoid Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Toxoid Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Toxoid Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Toxoid Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Toxoid Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Toxoid Sales by Region (2018-2024) & (K Units)
Table 94. Asia Toxoid Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Toxoid Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Toxoid Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Toxoid Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Toxoid Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Toxoid Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Toxoid Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Toxoid Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Toxoid Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Toxoid Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Toxoid Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Toxoid Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Toxoid Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Toxoid Sales by Country (2024-2029) & (K Units)
Table 108. Biocompare Company Information
Table 109. Biocompare Description and Major Businesses
Table 110. Biocompare Toxoid Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. Biocompare Toxoid Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Biocompare Recent Developments
Table 113. GSK Company Information
Table 114. GSK Description and Major Businesses
Table 115. GSK Toxoid Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. GSK Toxoid Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. GSK Recent Developments
Table 118. Zoetis Company Information
Table 119. Zoetis Description and Major Businesses
Table 120. Zoetis Toxoid Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. Zoetis Toxoid Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Zoetis Recent Developments
Table 123. Sanofi Company Information
Table 124. Sanofi Description and Major Businesses
Table 125. Sanofi Toxoid Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Sanofi Toxoid Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Sanofi Recent Developments
Table 128. Merck Company Information
Table 129. Merck Description and Major Businesses
Table 130. Merck Toxoid Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Merck Toxoid Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Merck Recent Developments
Table 133. Key Raw Materials Lists
Table 134. Raw Materials Key Suppliers Lists
Table 135. Toxoid Distributors List
Table 136. Toxoid Customers List
Table 137. Toxoid Market Trends
Table 138. Toxoid Market Drivers
Table 139. Toxoid Market Challenges
Table 140. Toxoid Market Restraints
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Toxoid Product Picture
Figure 2. Global Toxoid Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Toxoid Market Share by Type in 2022 & 2029
Figure 4. Tetanic Toxoid Product Picture
Figure 5. Diphtheria Toxoid Product Picture
Figure 6. Others Product Picture
Figure 7. Global Toxoid Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Toxoid Market Share by Application in 2022 & 2029
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Others
Figure 12. Toxoid Report Years Considered
Figure 13. Global Toxoid Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Toxoid Revenue 2018-2029 (US$ Million)
Figure 15. Global Toxoid Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Toxoid Revenue Market Share by Region (2018-2029)
Figure 17. Global Toxoid Sales 2018-2029 ((K Units)
Figure 18. Global Toxoid Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Toxoid Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada Toxoid Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Toxoid Sales YoY (2018-2029) & (K Units)
Figure 22. Europe Toxoid Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Toxoid Sales YoY (2018-2029) & (K Units)
Figure 24. China Toxoid Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Toxoid Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) Toxoid Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Toxoid Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America Toxoid Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Toxoid Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Toxoid in the World: Market Share by Toxoid Revenue in 2022
Figure 31. Global Toxoid Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Toxoid Sales Market Share by Type (2018-2029)
Figure 33. Global Toxoid Revenue Market Share by Type (2018-2029)
Figure 34. Global Toxoid Sales Market Share by Application (2018-2029)
Figure 35. Global Toxoid Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Toxoid Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Toxoid Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Toxoid Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Toxoid Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Toxoid Revenue Share by Country (2018-2029)
Figure 41. US & Canada Toxoid Sales Share by Country (2018-2029)
Figure 42. U.S. Toxoid Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Toxoid Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Toxoid Sales Market Share by Type (2018-2029)
Figure 45. Europe Toxoid Revenue Market Share by Type (2018-2029)
Figure 46. Europe Toxoid Sales Market Share by Application (2018-2029)
Figure 47. Europe Toxoid Revenue Market Share by Application (2018-2029)
Figure 48. Europe Toxoid Revenue Share by Country (2018-2029)
Figure 49. Europe Toxoid Sales Share by Country (2018-2029)
Figure 50. Germany Toxoid Revenue (2018-2029) & (US$ Million)
Figure 51. France Toxoid Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Toxoid Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Toxoid Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Toxoid Revenue (2018-2029) & (US$ Million)
Figure 55. China Toxoid Sales Market Share by Type (2018-2029)
Figure 56. China Toxoid Revenue Market Share by Type (2018-2029)
Figure 57. China Toxoid Sales Market Share by Application (2018-2029)
Figure 58. China Toxoid Revenue Market Share by Application (2018-2029)
Figure 59. Asia Toxoid Sales Market Share by Type (2018-2029)
Figure 60. Asia Toxoid Revenue Market Share by Type (2018-2029)
Figure 61. Asia Toxoid Sales Market Share by Application (2018-2029)
Figure 62. Asia Toxoid Revenue Market Share by Application (2018-2029)
Figure 63. Asia Toxoid Revenue Share by Region (2018-2029)
Figure 64. Asia Toxoid Sales Share by Region (2018-2029)
Figure 65. Japan Toxoid Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Toxoid Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Toxoid Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Toxoid Revenue (2018-2029) & (US$ Million)
Figure 69. India Toxoid Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Toxoid Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Toxoid Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Toxoid Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Toxoid Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Toxoid Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Toxoid Sales Share by Country (2018-2029)
Figure 76. Brazil Toxoid Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Toxoid Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Toxoid Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Toxoid Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Toxoid Revenue (2018-2029) & (US$ Million)
Figure 81. Toxoid Value Chain
Figure 82. Toxoid Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries